Annual Accounts Receivable
$11.35 M
-$6.57 M-36.64%
December 31, 2023
Summary
- As of February 7, 2025, AFIB annual accounts receivable is $11.35 million, with the most recent change of -$6.57 million (-36.64%) on December 31, 2023.
- During the last 3 years, AFIB annual accounts receivable has risen by +$9.19 million (+425.60%).
- AFIB annual accounts receivable is now -36.64% below its all-time high of $17.92 million, reached on December 31, 2022.
Performance
AFIB Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$9.97 M
+$735.00 K+7.96%
September 30, 2024
Summary
- As of February 7, 2025, AFIB quarterly accounts receivable is $9.97 million, with the most recent change of +$735.00 thousand (+7.96%) on September 30, 2024.
- Over the past year, AFIB quarterly accounts receivable has dropped by -$1.38 million (-12.18%).
- AFIB quarterly accounts receivable is now -44.36% below its all-time high of $17.92 million, reached on December 31, 2022.
Performance
AFIB Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AFIB Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.6% | -12.2% |
| 3 y3 years | +425.6% | +137.9% |
| 5 y5 years | +6822.6% | +302.5% |
AFIB Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.6% | +212.5% | -44.4% | +284.1% |
| 5 y | 5-year | -36.6% | +4216.7% | -44.4% | +3690.9% |
| alltime | all time | -36.6% | +6822.6% | -44.4% | +3690.9% |
Acutus Medical Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.97 M(+8.0%) |
| Jun 2024 | - | $9.23 M(+19.2%) |
| Mar 2024 | - | $7.75 M(-31.7%) |
| Dec 2023 | $11.35 M(-36.6%) | $11.35 M(+26.8%) |
| Sep 2023 | - | $8.95 M(+16.7%) |
| Jun 2023 | - | $7.67 M(+43.6%) |
| Mar 2023 | - | $5.34 M(-70.2%) |
| Dec 2022 | $17.92 M | $17.92 M(+457.7%) |
| Sep 2022 | - | $3.21 M(+23.8%) |
| Jun 2022 | - | $2.60 M(-12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.98 M(-18.0%) |
| Dec 2021 | $3.63 M(+68.2%) | $3.63 M(-13.3%) |
| Sep 2021 | - | $4.19 M(+24.7%) |
| Jun 2021 | - | $3.36 M(+35.6%) |
| Mar 2021 | - | $2.48 M(+14.7%) |
| Dec 2020 | $2.16 M(+721.3%) | $2.16 M(+14.1%) |
| Sep 2020 | - | $1.89 M(+120.1%) |
| Jun 2020 | - | $860.00 K(-11.4%) |
| Mar 2020 | - | $971.00 K(+269.2%) |
| Dec 2019 | $263.00 K(+60.4%) | $263.00 K |
| Dec 2018 | $164.00 K | - |
FAQ
- What is Acutus Medical annual accounts receivable?
- What is the all time high annual accounts receivable for Acutus Medical?
- What is Acutus Medical annual accounts receivable year-on-year change?
- What is Acutus Medical quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Acutus Medical?
- What is Acutus Medical quarterly accounts receivable year-on-year change?
What is Acutus Medical annual accounts receivable?
The current annual accounts receivable of AFIB is $11.35 M
What is the all time high annual accounts receivable for Acutus Medical?
Acutus Medical all-time high annual accounts receivable is $17.92 M
What is Acutus Medical annual accounts receivable year-on-year change?
Over the past year, AFIB annual accounts receivable has changed by -$6.57 M (-36.64%)
What is Acutus Medical quarterly accounts receivable?
The current quarterly accounts receivable of AFIB is $9.97 M
What is the all time high quarterly accounts receivable for Acutus Medical?
Acutus Medical all-time high quarterly accounts receivable is $17.92 M
What is Acutus Medical quarterly accounts receivable year-on-year change?
Over the past year, AFIB quarterly accounts receivable has changed by -$1.38 M (-12.18%)